Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about INM

Recent news which mentions INM

< Previous 1 2 3 4 5 6 7 Next >

BayMedica LLC: Working With Cannabis Multi-State Operators To Make Their Products Better

July 05, 2022

Marijuana As An Appetite Suppressant? It's A Possibility

June 30, 2022

InMed Pharmaceuticals: The Clinical-Stage Company Setting Sites On Dominating Rare Cannabinoid Production And Commercialization Across Global Markets

June 23, 2022

InMed Publishes Study On Potential Role Of Rare Cannabinoids For Skin Conditions

June 14, 2022

InMed Pharmaceuticals Announces $5 Million Registered Direct And Private Placement Offerings

June 02, 2022

InMed Pharmaceuticals Is Commercializing The Development Of Rare Cannabinoids For The Wellness Market

May 17, 2022

InMed Pharmaceuticals Reports Net Sales Of $575K For 6 Months Since BayMedica Acquisition

May 13, 2022

InMed Commercializes Rare Cannabinoids For Health And Wellness Market

May 09, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

May 03, 2022

20 Stocks Moving in Tuesday's Pre-Market Session

May 03, 2022

66 Biggest Movers From Yesterday

May 03, 2022

18 Stocks Moving in Tuesday's Pre-Market Session

April 26, 2022

InMed Pharmaceuticals (NASDAQ: INM) Announces Expansion Of Rare Cannabinoid Portfolio

April 22, 2022

InMed Pharmaceuticals (NASDAQ: INM) Announces Participation In Upcoming Conferences

April 20, 2022

InMed Pharmaceuticals Committed To Growing Market Reach, Product Portfolio

March 28, 2022

63 Biggest Movers From Yesterday

March 25, 2022

InMed Pharmaceuticals Makes Changes In Management

March 18, 2022

InMed Launching Additional Rare Cannabinoids In Response To Demand

March 17, 2022

InMed Pharmaceuticals Expanding Portfolio In Rare Cannabinoid Market

March 04, 2022

Stocks That Hit 52-Week Lows On Wednesday

March 02, 2022

InMed's Evolution To Commercial Sales Featured In Research Report

February 17, 2022

InMed Names BayMedica VP Of Sales, Releases Q2 2022 Report

February 16, 2022

InMed Positioned To Offer Rare Cannabinoid Manufacturing Technologies

February 15, 2022

InMed Pharmaceuticals To Release Q2 Financial Report, Update

February 11, 2022

InMed Pharmaceuticals Strengthens Leading Role In Rare Cannabinoid Market

February 04, 2022

InMed Pharmaceuticals Defining Value Of Rare Cannabinoids In Pharma Space

February 03, 2022

InMed Pharmaceuticals Expands Rare Cannabinoid Product Portfolio to Launch CBT

January 20, 2022

4 Penny Stocks Insiders Are Buying

January 07, 2022

InMed Pharmaceuticals' Issues Annual Shareholder Letter

January 05, 2022

InMed Pharmaceuticals to Present at Tribe Public's Webinar Event

December 30, 2021

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.